The annual fee that you pay to the fund company for managing your investment. The lower the expense ratio, the better. This is not an investment recommendation.

Dividends

1.46%Dividend Yield

Dec 25

$0.66

Dec 24

$0.24

Dec 23

$0.08

Dec 17

$0.3

Dec 15

$0.15

10Y Growth

N/A

5Y Growth

N/A

3Y Growth

99.7%

1Y Growth

N/A

People Also Follow

This list is based on the watchlists of people on Stock Events who follow BBC. It's not an investment recommendation.

Competitors

This list is an analysis based on recent market events. It's not an investment recommendation.

State Street SPDR S&P Biotech

XBI

Mkt Cap0

SPDR S&P Biotech ETF, tracks an equal-weighted index of US biotechnology stocks, directly competing in the biotech ETF space.

iShares Biotechnology

IBB

Mkt Cap0

iShares Biotechnology ETF, offers exposure to large and mid-sized biotech companies, a direct competitor in the biotech investment sector.

First Trust NYSE Arca Biotechnology Index Fund

FBT

Mkt Cap0

First Trust NYSE Arca Biotechnology Index Fund, tracks a tiered equal-weighted index of US biotechnology stocks, competing in biotech ETF offerings.

VanEck Biotech

BBH

Mkt Cap0

VanEck Vectors Biotech ETF, tracks a market-cap-weighted index of US biotech companies, competing for biotech-focused investment.

Principal Healthcare Innovators

BTEC

Mkt Cap0

Principal Healthcare Innovators Index ETF, focuses on early-stage healthcare innovation, including biotech, competing in the healthcare and biotech ETF market.

ARK Genomic Revolution

ARKG

Mkt Cap0

ARK Genomic Revolution ETF, invests in companies likely to benefit from extending and enhancing the quality of human and other life by incorporating technological and scientific developments, genomics, and biotechnology, a direct competitor in the innovative biotech space.

Invesco Biotechnology & Genome

PBE

Mkt Cap0

Invesco Dynamic Biotechnology & Genome ETF, tracks a tiered, equal-weighted index of US biotechnology and genome companies, competing in the dynamic biotech investment sector.

ALPS Medical Breakthroughs

SBIO

Mkt Cap0

ALPS Medical Breakthroughs ETF, focuses on small- and mid-cap biotechnology and pharmaceutical companies, a competitor targeting breakthrough medical innovations.

Direxion Daily S&P Biotech Bull 3X

LABU

Mkt Cap0

Direxion Daily S&P Biotech Bull 3X Shares, a leveraged ETF targeting the biotech sector, competes by offering amplified exposure to biotech stocks.

Direxion Daily S&P Biotech Bear 3X

LABD

Mkt Cap0

Direxion Daily S&P Biotech Bear 3X Shares, a leveraged ETF that offers inverse exposure to the biotech sector, competes by targeting investors looking for hedging or speculative opportunities in biotech.

Holdings

Regions

Sectors

About

The Fund seeks investment results that correspond, before fees and expenses, to the price and yield performance of the LifeSci Biotechnology Clinical Trials Index, which tracks the performance of select clinical trials stage biotechnology companies.Effective February 27, this Fund's name changed from Virtus LifeSci Biotech Clinical Trials ETF to Virtus Biotech Clinical Trials ETF.

CEO

Country

United States

ISIN

US26923G3011

Listings

0 Comments

Share your thoughts

FAQ

What is Virtus Biotech Clinical Trials stock price today?▼

The current price of BBC is $44.84 USD — it has increased by +0.06% in the past 24 hours. Watch Virtus Biotech Clinical Trials stock price performance more closely on the chart.

What is Virtus Biotech Clinical Trials stock ticker?▼

Depending on the exchange, the stock ticker may vary. For instance, on exchange Virtus Biotech Clinical Trials stocks are traded under the ticker BBC.

Is Virtus Biotech Clinical Trials stock price growing?▼

BBC stock has risen by +4.74% compared to the previous week, the month change is a +4.82% rise, over the last year Virtus Biotech Clinical Trials has showed a +161.46% increase.

Does Virtus Biotech Clinical Trials pay dividends?▼

Yes, BBC dividends are paid annual. The last dividend per share was 0.66 USD. As of today, Dividend Yield (FWD)% is 1.46%.

In which sector is Virtus Biotech Clinical Trials located?▼

Virtus Biotech Clinical Trials operates in the Other sector.

When did Virtus Biotech Clinical Trials complete a stock split?▼

Virtus Biotech Clinical Trials has not had any recent stock splits.